DELETERIOUS BRCA1 GENE MUTATION
Clinical trials for DELETERIOUS BRCA1 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new DELETERIOUS BRCA1 GENE MUTATION trials appear
Sign up with your email to follow new studies for DELETERIOUS BRCA1 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested in battle against Tough-to-Treat gynecologic cancers
Disease control OngoingThis early-stage study is testing a combination of two drugs, niraparib (a pill) and copanlisib (an IV infusion), for women whose ovarian, endometrial, or related cancers have returned after prior treatment. The main goals are to find the safest dose of this combination and to le…
Matched conditions: DELETERIOUS BRCA1 GENE MUTATION
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New study tests less drastic surgery to prevent ovarian cancer
Prevention OngoingThis study is comparing two different surgeries to prevent ovarian cancer in premenopausal women who have inherited genetic mutations that put them at high risk. One surgery removes both the fallopian tubes and ovaries at once, while the other removes just the tubes first and del…
Matched conditions: DELETERIOUS BRCA1 GENE MUTATION
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Mar 23, 2026 15:18 UTC
-
Can learning to feel hungry help prevent cancer?
Prevention OngoingThis study is testing if a diabetes prevention program, with or without extra training on recognizing hunger, can help people at high risk for breast cancer lose weight. The goal is to see if weight loss from these programs might lower cancer risk. The study enrolled 51 overweigh…
Matched conditions: DELETERIOUS BRCA1 GENE MUTATION
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Mar 18, 2026 14:41 UTC